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Abstract
Gene therapeutics provides great opportunities for curing diabetes. Numerous attempts have been made to
establish a safe and high-efficiency gene delivery strategy, but all of them are unsuccessful. To achieve an ideal
transfection, a novel gene delivery strategy was presented in this research. The novel system proposed was
transfection mediated by the combination of ultrasound with microbubbles and cross-linked polyethylenimines
(PEIs). Ultrasound with microbubbles enhances the permeability of target cells; moreover, cross-linked PEIs enabled
DNA to escape from endosomes into the cytoplasm. If the proposed method is feasible and effective, the
endogenous secretion system of insulin would be re-established in patients with diabetes.
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Background
Currently, diabetes mellitus has become a severe global
public healthcare problem due to the increasing preva-
lence, morbidity, and mortality. Islet transplantation has
become a promising strategy for curing diabetes follow-
ing the success of the “Edmonton protocol” [1]. How-
ever, islet transplantation is limited by both scarcity of
donor cells and requirement for life-long immunosup-
pressive therapy. Gene therapeutics has been heavily in-
vestigated to be a new treatment for this disease. The
most pivotal task is to achieve a clinically safe and effi-
cient gene delivery method.
In the last two decades, transgenic system based on
viral vectors held promises for gene delivery for the effi-
cient delivery and long-term expression of transgenes to
target cells [2]. It was documented that viral vectors-
mediated transgenes in hepatocytes could ameliorate
hyperglycemia in mice [3, 4]. By 2012, viral vectors have
been employed as gene carriers in most of researches
and clinical trials [5]. However, safety concerns in gene
delivery have been highly controversial. Theoretically,
viral vectors would induce unexpected immune response
and oncogenic effects. In fact, a tragic gene therapy
death of a volunteer in a clinical study was caused by ad-
ministering a high dosage of an adenovirus vector within
98 h [6]. The post-mortem examination revealed that
the patient died of multi-organ failure due to the fatal
immune response triggered by the administered adeno-
virus [7].
Non-viral approaches have also been extensively inves-
tigated as alternatives over past a few years. Compared
to viral methods, they are likely to present fewer toxic
and immunological problems. However, inefficient gene
transfer was still their “Achilles heel” currently [8]. It is
believed that when only a new non-viral method is ex-
plored, the large-scale clinical application of gene ther-
apy would be allowed.
Presentation of the Hypothesis
Given the need, a novel therapeutic strategy using ultra-
sound (US) with microbubbles technology has entered
the realm of gene delivery. Firstly, microbubbles, encap-
sulating gas in micron-sized shell, were introduced as
US contrast agent to improve the ultrasonic imaging [9].
Recent investigations suggested that US with the aid of
microbubbles is a potential novel method for the gene
therapy in various diseases, both in vivo [10, 11] and in
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Fig. 2 Scheme of the patient-specific therapy using cell-reprogramming technology. Hepatocytes are obtained from a diabetic patient by a
laparoscopic partial hepatectomy. Cross-linked polyethylenimine (PEI)-DNA complexes are transfected into these hepatocytes with the aid of
ultrasound (US) with microbubbles. The transfection leads to trans-differentiation from hepatocytes into insulin-producing cells (IPCs). The induced
IPCs are auto-transplanted to the liver via laparoscopic portal injection, to re-establish the endogenous secretion system of insulin
Fig. 1 Schematic drawing of gene transfection by the combination of US with microbubbles and cross-linked PEIs. On one hand, sonoporation of
US allows cross-linked PEI-DNA complexes into the cytoplasm. On the other hand, US can enhance endocytosis. The complexes will escape from
the endosome to the cytoplasm. After reaching the cytoplasm, all the complexes will degrade into their low molecular-weight components and
release DNA to enter the nucleus for transcription
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vitro studies [12, 13]. It was addressed that gas-filled
microbubbles were driven in US field, and induced shear
stresses and sudden ruptures, which subsequently gener-
ated force and then punctured on the surrounding cells
and tissues, which was termed as sonoporation [14]. Fi-
nally, reversible pores resulted from the force enhanced
the permeability of the cell membrane temporarily and
permitted foreign genes into cells [12, 15, 16]. Besides,
endocytosis stimulated by US is another reason for the
facilitation of this gene delivery system [17]. Compared
with viral methods, many desirable features of gene ther-
apy such as safety, low cytotoxicity, low immunogenicity,
and low cost can be found in the gene delivery strategy
of US with microbubbles. Whereas this protocol still
suffers from the drawback of insufficient transfection
efficiency [18, 19].
Cross-linked polyethylenimine (PEI) is a vector tailor-
made for gene delivery, which was synthesized by adding
800-Da PEIs to small diacrylate cross-linkers. The de-
gradable polymers exhibited characteristics of similar in
structure, size, and DNA-binding properties to off-the-
shelf 25-kDa PEI. Notably, they are essentially non-toxic
for high efficiencies [20]. Compact nanoparticles are
formed through electrostatic attraction between negative
charge DNA and positive charge cross-linked PEIs.
These particles can escape from the endosomes into the
cytoplasm, and prevent DNA from being digested [21].
After reaching the cytoplasm, the particles will decom-
pose into their low molecular-weight components, which
are believed to be essentially non-toxic, and then release
DNA to enter the nucleus for transcription. Moreover,
the synergistic effect of transfection efficiency in com-
bination of US with microbubbles and 25-kDa PEIs was
found in Tu and his colleagues’ study [22]. Therefore, we
believe that greater transfection efficiency might be
achieved via the combination of US with microbubbles
and cross-linked PEIs (Fig. 1).
Implications of the Hypothesis
It was proved that transfection with Pdx1, Ngn3, and
MafA was a most efficient combination in reprogram-
ming hepatocytes into insulin-producing cells that
closely resemble endogenous β -cells in our previous
study [23]. It is expected that a safer and more efficient
transfection can be achieved by our proposed gene deliv-
ery strategy. Laparoscopic approach has been confirmed
as a reliable therapeutic option in hepatectomy. There-
fore, it is also expected that diabetes could be cured by
their own reprogrammed hepatocytes via introducing
Pdx1, Ngn3, and MafA (Fig. 2).
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